Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study
NCT ID: NCT01669954
Last Updated: 2012-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
440 participants
OBSERVATIONAL
2009-02-28
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This will enable a practical approach to screening for osteoporosis and the management and prevention of fragility fractures in people with HIV.
In addition, all risk factors commonly associated with fragility fractures and osteoporosis are collected, as is HIV drug history.
Hence, as secondary outcomes, the associations with reduced bone mineral density can be ascertained.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device
NCT07187518
Improved Screening for Osteoporosis
NCT02066480
Screening for Osteoporosis in General Practice
NCT02220699
Clinical Study to Predict the Risk of Bone Fractures With the POROUS Ultrasound Device
NCT06567054
Bone Health and Vitamin D Status
NCT01634607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controls, females
Controls who are presumed HIV uninfected, females, aged 18 or above
No interventions assigned to this group
Controls, males
Controls presumed HIV uninfected, males, aged 18 or above
No interventions assigned to this group
HIV infected patients, males
HIV patients, males, aged 18 or above
No interventions assigned to this group
HIV patients,
HIV patients, females, aged 18 or above
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St Thomas' Hospital, London
OTHER
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barry Stephen Peters
Reader and Consultant HIV Medicine, Head of Research Unit, Principle Investigator, Clinical Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barry S Peters, MD PhD
Role: PRINCIPAL_INVESTIGATOR
King's College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Thomas, Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08/H0805/56
Identifier Type: OTHER
Identifier Source: secondary_id
RJ1 09/0329
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.